Is there really good news about pandemic diabetic nephropathy?

Nephrology Dialysis Transplantation

Volumn 22, Issue 3, 2007, Pages 681-683

  Friedman, Eli A ^a   Friedman, Amy L ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Diabetic nephropathy; End stage renal failure (ESRD); Epidemiology; Pandemic; Renoprotection; Uraemia; USRDS

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CLINICAL EFFECTIVENESS; COMORBIDITY; DATA ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIALYSIS; DISEASE DURATION; DYSLIPIDEMIA; EXERCISE; HEALTH CARE COST; HEALTH CARE PLANNING; HEREDITY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INFORMATION DISSEMINATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; METABOLIC REGULATION; MICROALBUMINURIA; NOTE; PANDEMIC; PATIENT CARE; PRIORITY JOURNAL; REGISTER; RENAL PROTECTION; RISK ASSESSMENT; SMOKING CESSATION; UNITED STATES; WEIGHT REDUCTION;

ADULT; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; MORBIDITY; PROGNOSIS; RENAL REPLACEMENT THERAPY; UREMIA; WORLD HEALTH;

EID: 33847637080     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl735     Document Type: Note

References (20)

1. Merriam-Webster's Medical Dictionary, Merriam-Webster, Inc Springfield, MA, USA, 2002.
2. Camille AJ, Krowleski AS, Rogus J, Xue JL, Collins A, Warram JH. Epidemic of end-stage renal disease in people with diabetes in the United States Population: Do we know the cause? Kidney Int 2005; 67: 1684-1691
3. Engelgau MM, Geiss LS, Saaddine JB et al. The evolving diabetes burden in the United States. Ann Intern Med 2004; 140: 945-950
4. US Renal data system: USRDS 2005 Annual Data Report, Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005
5. Reuters News Service, London. Diabetes could cripple health budgets, says expert american diabetes association 14 September 2006. http://www.diabetes.org/diabetesnewsarticle.jsp?storyId= 13343707&filename=20060914/ reuters20060914health00000004reutershealthewEDIT.xml.
6. JDRF Applauds International Campaign to Halt Global Diabetes Epidemic. 24 July 2006. http://www.jdrf.org/index.cfm?page_id=105420
7. CDC. 1997 National Health Interview Survey (NHIS) public use data release: NHIS survey description. Hyattsville, MD: US Department of Health and Human Services, CDC;2000. Available at ftp://ftp.cdc.gov/pub/ health_statistics/nchs/dataset_documentation/nhis/1997/srvydesc.pdf
8. Burrows NR, Wang J, Geiss LS, Venkat Narayan KM, Engelgau MM, Div of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion. Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention, Atlanta, GA, 4 November 2005; 54: 1097-1100
9. Nelson RG, Knowler WC, Pettitt DJ, Bennett PH. Kidney diseases in diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, eds. Diabetes in America, 2nd edn, US Department of Health and Human Services, National Institutes of Health, Washington, DC: 1995. DHHS publication no. (NIH) 95-1468; 361-366
10. Miyata T, de YS. Renoprotection of angiotensin receptor blockers: Beyond blood pressure lowering. Nephrol Dial Transplant 2006; 10: 1-4
11. So WY, Ma RC, Ozaki R et al. Angiotensin-Converting Enzyme (ACE) inhibition in type 2, diabetic patients-interaction with ACE insertion/ deletion polymorphism. Kidney Int 2006; 69: 383-387
12. American Diabetes Association b, Clinical Practice Recommendations 2006, Standards of Medical Care in Diabetes-2006. Hypertension/blood pressure control. Diabetes Care 2006;29 [Suppl 1]: S17-S18
13. Kong AP, So WY, Szeto CC et al. Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney Int 2006; 69: 383-387
14. Bode BW, Schwartz S, Stubbs HA, Block JE. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 2005; 28: 2361-2366
15. Dijkstra RF, Niessen LW, Braspenning JC, Adang E, Grol RT. Patient-centred and professional-directed implementation strategies for diabetes guidelines: A cluster-randomized trial-based cost-effectiveness analysis. Diabet Med 2006; 23: 164-170
16. American Diabetes Association d, Clinical Practice Recommendations 2006, Standards of Medical Care in Diabetes-2006. Dyslipidemia/lipid management. Diabetes Care 2006; 29 [Suppl 1]: S18-S19.
17. Ridderstrale M, Gudbjornsdottir S, Eliasson B, Nilsson PM, Cederholm J. For the Steering Committee of the Swedish National Diabetes Register (NDR). Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med 2006; 259: 314-322.
18. Ritz E, Schwenger V. Lifestyle modification and progressive renal failure. Nephrology (Carlton) 2005; 10: 387-392
19. Enserink M. Influenza: New study casts doubt on plans for pandemic containment. Science 2006; 24: 311-1084
20. Kaufman M. Smoking in U.S. declines sharply. Cigarette sales at a 54-year low. Wasington Post, 9 March 2006, A01.